Delivery Order SPE2DB22D3301-SPE2DB25FY2ZF

Award Date 4/9/25
Potential Completion Date 4/10/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $11,538.62 and covers the delivery of 4,567,922,191 units of the prescription medication Lyrica 50 mg capsules. The contract has an ultimate completion date of April 16, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 75 mg capsules. The contract has a ceiling value of $1,923.45 and a period of performance through May 1, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,454.04 to provide Lyrica 75 mg capsules. This award is part of a larger, single-award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 held by Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,736.28 firm-fixed-price contract is for the supply of Lyrica 75 mg capsules. The contract has an ultimate completion date of February 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,812.70, is for the supply of Lyrica 75 mg capsules. The contract has an ultimate completion date of August 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the supply of Lyrica 75 mg capsules, with a ceiling value of $1,083.92 and a completion date of April 2, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,359.54, is for the supply of Lyrica 100 mg capsules. The contract has a firm fixed-price pricing type and an ultimate completion date of March 19, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,239.04, is for the delivery of Lyrica 75 mg capsules. The contract has an ultimate completion date of November 5, 2024 and is a firm fixed-price type. This contract is a child award under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.82 firm-fixed-price delivery order is for the supply of Lyrica 75 mg capsules, a medication used to treat certain types of nerve pain. The contract has a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lyrica 75 mg capsules in 90-count bottles. The contract, valued at $1,669.62, was awarded on June 17, 2024 by the Defense Logistics Agency (DLA), with a completion date of June 18, 2024. The contract is a firm-fixed price delivery order, without a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY2ZF
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,445.82, is for the delivery of 4,567,860,790 units of Lyrica 75 mg capsules. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 7/9/25, 10:05 AM